What one share of Lb Pharmaceuticals holds
We are a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder and other diseases.
Lb Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$3.84 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$3.71 |
| Cash and investments | $11.43 |
| Book value | $11.59 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | — | −$176.15 | $2.15 | −$150.24 | — | −$375.73 |
| 2025 | — | −$3.13 | $0.01 | −$4.38 | — | $11.91 |
Common questions about Lb Pharmaceuticals
How much does one share of Lb Pharmaceuticals earn?
Over the last 12 months, Lb Pharmaceuticals lost $3.84 for each share.
Does Lb Pharmaceuticals pay a dividend?
Lb Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Lb Pharmaceuticals’s book value per share?
Lb Pharmaceuticals’s book value is $11.59 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Lb Pharmaceuticals have?
Each share of Lb Pharmaceuticals has $11.43 of cash and investments, as of June 30, 2026.
What is Lb Pharmaceuticals’s free cash flow per share?
−$3.71 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.